18504-27-3 Usage
General Description
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is a chemical compound that is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It is a nitroimidazole derivative, which means it contains a nitro group and an imidazole ring in its structure. 1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is known for its antimicrobial and antiparasitic properties, and it is often used in the development of drugs to treat infections caused by bacteria and parasites. Additionally, it has been studied for its potential anti-cancer properties, as well as its use as a radioprotective agent. Overall, 1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole has a wide range of potential applications in the field of medicine and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 18504-27-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,5,0 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 18504-27:
(7*1)+(6*8)+(5*5)+(4*0)+(3*4)+(2*2)+(1*7)=103
103 % 10 = 3
So 18504-27-3 is a valid CAS Registry Number.
18504-27-3Relevant articles and documents
Crystal Habit Modification of Metronidazole by Supramolecular Gels with Complementary Functionality
Jayabhavan, Sreejith Sudhakaran,Steed, Jonathan W.,Damodaran, Krishna K.
, p. 5383 - 5393 (2021)
A series of bis(urea) compounds with complementary functional groups similar to the pharmaceutical drug metronidazole and a structural isomer isometronidazole have been synthesized. The gelation properties of these compounds were studied in various solvent/solvent mixtures. The mechanical strength of the isomeric gelators was compared using rheology, and the morphologies of the xerogels were analyzed by scanning electron microscopy. These gels were used as media for metronidazole crystallization resulting in a marked habit modification of the metronidazole crystals in the drug-mimicking gels. However, crystallization in the nonmimetic isomeric gel resulted in morphologies similar to the solution state. These results indicate that the drug-mimetic gels interact with the surface of the drug crystal giving rise to new morphologies.
